Free Trial

Invesco Ltd. Trims Position in The Cooper Companies, Inc. (NASDAQ:COO)

Cooper Companies logo with Medical background
Remove Ads

Invesco Ltd. decreased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 2.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,846,881 shares of the medical device company's stock after selling 147,164 shares during the period. Invesco Ltd. owned 2.43% of Cooper Companies worth $445,574,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Byrne Asset Management LLC purchased a new stake in Cooper Companies in the 4th quarter valued at about $33,000. OFI Invest Asset Management purchased a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $34,000. New Age Alpha Advisors LLC acquired a new position in shares of Cooper Companies in the 4th quarter worth approximately $38,000. West Financial Advisors LLC purchased a new position in shares of Cooper Companies during the 4th quarter worth approximately $49,000. Finally, Atala Financial Inc acquired a new stake in Cooper Companies in the 4th quarter valued at approximately $51,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on COO shares. Robert W. Baird decreased their target price on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. BNP Paribas raised Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Citigroup reduced their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Finally, Piper Sandler reiterated an "overweight" rating and set a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $110.25.

Remove Ads

Get Our Latest Stock Analysis on COO

Cooper Companies Stock Up 1.0 %

Shares of NASDAQ COO traded up $0.81 during mid-day trading on Monday, reaching $78.27. The company had a trading volume of 382,495 shares, compared to its average volume of 1,392,175. The Cooper Companies, Inc. has a 52-week low of $69.81 and a 52-week high of $112.38. The stock has a market cap of $15.65 billion, a P/E ratio of 40.14, a PEG ratio of 2.25 and a beta of 1.01. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm has a 50 day simple moving average of $84.64 and a two-hundred day simple moving average of $94.52.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The business had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Further Reading

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads